Skip to Content

Ripretinib (Qinlock®) for Treatment of Adults with Advanced Gastrointestinal Stromal Tumors

Download PQI pdf 0.19MB

Last Updated: February 8, 2024

By: Joseph Bubalo PharmD

About this PQI

The purpose of this PQI is to summarize the process for initiating and monitoring ripretinib therapy in patients with advanced gastrointestinal stromal tumor (GIST).

More About This PQI

PQI in Action Articles:

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care. Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Find a PQI